Showing 1 - 3 results of 3 for search 'M-C Kyrtsonis', query time: 0.02s Refine Results
  1. 1
    PB1957: CIRCULATING MIRNA-16 AND MIRNA -21 EXPRESSION LEVELS IN MYELOMA; PRELIMINARY RESULTS.

    PB1957: CIRCULATING MIRNA-16 AND MIRNA -21 EXPRESSION LEVELS IN MYELOMA; PRELIMINARY RESULTS. by A.-I. Gkioka, M. Tsota, M. Papadatou, A. Gkiokas, A. Alexandropoulos, V. Bartzi, G. V. Dedousis, M.-C. Kyrtsonis

    Published 2022-06-01
    Get full text
    Article
  2. 2
    P16: DARATUMUMAB MONOTHERAPY HAS A FAVORABLE EFFECT ON BONE METABOLISM IN PATIENTS WITH RELAPSED/REFRACTORY MULTIPLE MYELOMA; RESULTS OF THE PHASE 2 REBUILD STUDY

    P16: DARATUMUMAB MONOTHERAPY HAS A FAVORABLE EFFECT ON BONE METABOLISM IN PATIENTS WITH RELAPSED/REFRACTORY MULTIPLE MYELOMA; RESULTS OF THE PHASE 2 REBUILD STUDY by E Terpos, I Ntanasis-Stathopoulos, E Kastritis, E Hatjiharissi, E Katodritou, E Eleutherakis-Papaiakovou, E Verrou, M Gavriatopoulou, A Leonidakis, S Delimpasi, P Malandrakis, M-C Kyrtsonis, M Papaioannou, A Symeonidis, MA Dimopoulos

    Published 2022-04-01
    Get full text
    Article
  3. 3
    P916: COEXISTENCE OF ≥2 HIGH-RISK MOLECULAR ABNORMALITIES SUPERVENES THE PROGNOSTIC VALUE OF THE REVISED INTERNATIONAL STAGING SYSTEM FOR MYELOMA: REAL-WORLD DATA ANALYSIS FROM THE GREEK MYELOMA STUDY GROUP

    P916: COEXISTENCE OF ≥2 HIGH-RISK MOLECULAR ABNORMALITIES SUPERVENES THE PROGNOSTIC VALUE OF THE REVISED INTERNATIONAL STAGING SYSTEM FOR MYELOMA: REAL-WORLD DATA ANALYSIS FROM THE... by E. Katodritou, D. Dalampira, T. Triantafyllou, M. Gavriatopoulou, S. Delimpasi, A. Pouli, T. Papadopoulou, E. Verrou, A. Sevastoudi, K. Tsirou, L. Katsika, G. Douganiotis, N. Karampatzakis, T.-E. Metallinou, V. Palaska, M. Kotsopoulou, C. Lalayianni, M.-C. Kyrtsonis, E. Spanoudakis, D. Maltezas, A. Chatzivasili, M.-A. Dimopoulos, E. Terpos, E. Kastritis

    Published 2022-06-01
    Get full text
    Article

Search Tools: